MXCT logo

MaxCyte (MXCT) Company Overview

Profile

Full Name:

MaxCyte, Inc.

Sector:

Healthcare

Country:

United States

IPO:

July 30, 2021

Indexes:

Not included

Description:

MaxCyte (MXCT) is a biotechnology company that specializes in cell engineering and drug development. They provide technology and services to help researchers and companies create and improve cell-based therapies, focusing on areas like cancer and genetic diseases. Their innovative platform supports faster and more efficient research.

Events Calendar

Earnings

Next earnings date:

Mar 11, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

Mar 12, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Apr 23, 24 Stephens & Co.
Overweight
Mar 13, 24 Stephens & Co.
Overweight
Mar 13, 24 BTIG
Buy
Nov 29, 23 Craig-Hallum
Buy
Oct 5, 23 Stephens & Co.
Overweight
Mar 28, 23 Stephens & Co.
Overweight
Aug 15, 22 BTIG
Buy
Aug 24, 21 William Blair
Outperform
Aug 24, 21 Stifel
Buy
Aug 24, 21 Stephens & Co.
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for MaxCyte?
  • Does MaxCyte pay dividends?
  • What sector is MaxCyte in?
  • What industry is MaxCyte in?
  • What country is MaxCyte based in?
  • When did MaxCyte go public?
  • Is MaxCyte in the S&P 500?
  • Is MaxCyte in the NASDAQ 100?
  • Is MaxCyte in the Dow Jones?
  • When was MaxCyte's last earnings report?
  • When does MaxCyte report earnings?
  • Should I buy MaxCyte stock now?

What is the ticker symbol for MaxCyte?

The ticker symbol for MaxCyte is NASDAQ:MXCT

Does MaxCyte pay dividends?

No, MaxCyte does not pay dividends

What sector is MaxCyte in?

MaxCyte is in the Healthcare sector

What industry is MaxCyte in?

MaxCyte is in the Medical Devices industry

What country is MaxCyte based in?

MaxCyte is headquartered in United States

When did MaxCyte go public?

MaxCyte's initial public offering (IPO) was on July 30, 2021

Is MaxCyte in the S&P 500?

No, MaxCyte is not included in the S&P 500 index

Is MaxCyte in the NASDAQ 100?

No, MaxCyte is not included in the NASDAQ 100 index

Is MaxCyte in the Dow Jones?

No, MaxCyte is not included in the Dow Jones index

When was MaxCyte's last earnings report?

MaxCyte's most recent earnings report was on Nov 6, 2024

When does MaxCyte report earnings?

The next expected earnings date for MaxCyte is Mar 11, 2025

Should I buy MaxCyte stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions